Intelligence · Clinical pipeline
Phase III Pipeline Programs
Late-stage pivotal and registrational clinical programs nearing regulatory submission.
Quick answer
NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.
Top sponsors
- Takeda 393 programs
- United Therapeutics Europe 199 programs
- Anaxis Pharma 198 programs
- Chinese Academy of 189 programs
- Teva Pharma 148 programs
- Novartis India 145 programs
- BRIGHT MINDS BIOSCIENCES 139 programs
- PARItec 139 programs
- HOFFMANN-LA ROCHE 134 programs
- Regeneron UK 129 programs
- AstraZeneca 120 programs
- First People's Hospital 117 programs
Pipeline programs
-
Placebos
Jian Li
Advanced Non-small Cell Lung Cancer
1 trial -
Plasma exchange
Ultragenyx UK Limited
Acute Disseminated Encephalomyelitis
1 trial -
Platelet Rich Plasma
Hospital Authority, Hong Kong
Severe Oligoasthenoteratozoospermia
1 trial -
Platelet Rich Plasma Injection
United Therapeutics Europe Ltd
Osteoarthritis of the Shoulder
1 trial -
Platelet rich plasma
Lxo Ireland Designated Activity Company
Coxarthrosis
1 trial -
Plozasiran
Arrowhead Pharmaceuticals Ireland Limited
Severe Hypertriglyceridemia
1 trial -
Plozasiran
Arrowhead Pharmaceuticals Ireland Limited
Familial Chylomicronemia
1 trial -
Plozasiran
Arrowhead Pharmaceuticals Ireland Limited
Familial Chylomicronemia Syndrome
1 trial -
Plozasiran Injection
Arrowhead Pharmaceuticals Ireland Limited
Hypertriglyceridemia
2 trials -
Plozasiran Injection
Arrowhead Pharmaceuticals Ireland Limited
Severe Hypertriglyceridemia
2 trials -
Plozasiran Injection Placebo, ARO-APOC3 PFS
Arrowhead Pharmaceuticals Ireland Limited
Severe hypertriglyceridemia (SHTG)
1 trial -
Plozasiran Injection Placebo, ARO-APOC3 PFS
Arrowhead Pharmaceuticals Ireland Limited
Severe hypertriglyceridemia (SHTG)
1 trial -
Policosanol
BRIGHT MINDS BIOSCIENCES INC.
Hypercholesterolemia
1 trial -
PolyCore
Lacuna Pharma Pty Ltd
Congestive Heart Failure
1 trial -
Polyamide HD membrane
Sionna Therapeutics
End-stage Kidney Disease
1 trial -
Ponatinib
Takeda
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
1 trial -
Ponatinib 30 mg QD
Takeda
Chronic Phase Chronic Myeloid Leukemia
1 trial -
Ponatinib-3001
Takeda
Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
1 trial -
Ponesimod
Vanda Pharmaceuticals Netherlands B.V.
Moderate-to-severe Chronic Plaque Psoriasis
1 trial -
Posterior Approach Compression Distraction Reduction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Basilar Invagination Associated With Atlantoaxial Dislocation
1 trial -
Povetacicept
Vertex Pharmaceuticals (Australia) Pty.
Primary Membranous Nephropathy
1 trial -
Povetacicept
Vertex Pharmaceuticals (Australia) Pty.
Immunoglobulin A Nephropathy
1 trial -
Povorcitinib
Incyte
Hidradenitis Suppurativa (HS)
1 trial -
Povorcitinib, Placebo to Povorcitinib
Incyte
Vitiligo
1 trial -
Povorcitinib, Povorcitinib
Incyte
Hidradenitis Suppurativa
1 trial -
Powder for reconstitution for enteral administration
Lacuna Pharma Pty Ltd
Intestinal Malabsorption
1 trial -
Powder for reconstitution for enteral administration
Lacuna Pharma Pty Ltd
Intestinal Malabsorption
1 trial -
Pozelimab
Regeneron UK Limited
CD55-deficient Protein-losing Enteropathy
1 trial -
Pozelimab
Regeneron UK Limited
Age-related Macular Degeneration (AMD)
1 trial -
Pozelimab
Regeneron UK Limited
Paroxysmal Nocturnal Hemoglobinuria
4 trials -
Pozelimab + Cemdisiran
Regeneron UK Limited
Generalized Myasthenia Gravis
1 trial -
Pozelimab, Cemdisiran
Lacuna Pharma Pty Ltd
Paroxysmal nocturnal hemoglobinuria (PNH)
1 trial -
Pramipexol Extended Release
Boehringer Ingelheim
Early Parkinson Disease (Early PD)
1 trial -
Pravafenix 40 mg/160 mg hard capsules
Laboratoire HRA Pharma
Dyslipidaemia
1 trial -
Prednisolone
United Therapeutics Europe Ltd
Adrenal Insufficiency
1 trial -
Pregabalin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Herpetic Neuralgia
1 trial -
Pregabalin Dose Level 1
Pfizer
Partial Onset Seizures
1 trial -
Pretomanid
BRIGHT MINDS BIOSCIENCES INC.
Tuberculosis, Pulmonary
2 trials -
Prevnar 13™
Merck KGaA, Darmstadt, Germany
Pneumococcal Infections
1 trial -
Probiotic in AL amyloidosis
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Immunoglobulin Light-chain Amyloidosis
1 trial -
Probuphine (buprenorphine implant)
BRIGHT MINDS BIOSCIENCES INC.
Opioid Dependency
1 trial -
Progesterone
TherapeuticsMD
Secondary Amenorrhea
1 trial -
Progesterone
United Therapeutics Europe Ltd
Alcohol Dependence
1 trial -
Progesterone supplementation
Hospital Authority, Hong Kong
Assisted Reproductive Technology
1 trial -
Prompt aflibercept
Regeneron UK Limited
Diabetic Retinopathy
1 trial -
Prompt aflibercept
Regeneron UK Limited
Diabetic Macular Edema
1 trial -
Propranolol
United Therapeutics Europe Ltd
Burn
1 trial -
Prostavue
Curium Romania S.R.L.
Prostate cancer
1 trial
Frequently asked questions
How many Phase III pipeline programs are in the directory?
5,427 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.